Matrix Trust Company’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$38K Buy
150
+54
+56% +$12.6K 0.01% 88
2026
Q1
$23K Sell
96
-123
-56% -$28.6K ﹤0.01% 107
2025
Q4
$45K Sell
219
-898
-80% -$178K 0.01% 126
2025
Q3
$207K Sell
1,117
-1
-0.1% -$171 0.03% 128
2025
Q2
$171K Buy
1,118
+136
+14% +$20.9K 0.03% 136
2025
Q1
$163K Buy
982
+146
+17% +$22.8K 0.03% 132
2024
Q4
$121K Sell
836
-10,573
-93% -$1.64M 0.02% 128
2024
Q3
$1.85M Buy
11,409
+42
+0.4% +$6.69K 0.35% 37
2024
Q2
$1.66M Buy
11,367
+496
+5% +$73.8K 0.38% 37
2024
Q1
$1.72M Buy
10,871
+157
+1% +$25K 0.39% 33
2023
Q4
$1.68M Sell
10,714
-26
-0.2% -$3.99K 0.39% 34
2023
Q3
$1.67M Hold
10,740
0.44% 27
2023
Q2
$1.78M Buy
10,740
+3,455
+47% +$558K 0.46% 27
2023
Q1
$1.13M Sell
7,285
-2,067
-22% -$334K 0.3% 46
2022
Q4
$1.65M Buy
9,352
+3,038
+48% +$525K 0.42% 26
2022
Q3
$1.03M Buy
6,314
+1,892
+43% +$320K 0.29% 26
2022
Q2
$785K Buy
4,422
+2,865
+184% +$510K 0.22% 29
2022
Q1
$276K Buy
+1,557
New +$265K 0.07% 36

Other funds holding JNJ

Matrix Trust Company's JNJ Position: Q2 2026 in Review

Matrix Trust Company increased its Johnson & Johnson (JNJ) stake by 56% in Q2 2026, buying an estimated $12.6K and bringing the position to 150 shares worth $38K. The position accounts for 0.01% of the portfolio, ranked #88.

Matrix Trust Company first reported a position in JNJ in Q1 2022 and has held it in 18 quarters since. The position peaked at $1.85M in Q3 2024. 899 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Matrix Trust Company held 150 shares of Johnson & Johnson worth $38K as of Q2 2026.
  • Matrix Trust Company bought 54 Johnson & Johnson shares in Q2 2026, an estimated $12.6K.
  • Johnson & Johnson made up 0.01% of Matrix Trust Company's portfolio in Q2 2026, its #88 holding.
  • Matrix Trust Company first reported a position in Johnson & Johnson in Q1 2022 and has held it in 18 quarters since.
  • Matrix Trust Company's Johnson & Johnson position peaked at $1.85M in Q3 2024.
  • 899 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Matrix Trust Company's 13F filing for Q2 2026, filed 9 Jul 2026.